Resources
Proteomics Databases
Metabolomics Databases

-
• What is Polyclonal Antibody Sequencing?
Learn what polyclonal antibody sequencing is, how it differs from monoclonal sequencing, what outputs it produces, and when mass spectrometry is used to characterize polyclonal IgG.
-
A technical guide explaining how non-denaturing native mass spectrometry reveals protein complexes, stoichiometry, and binding states for intact protein and biologics characterization.
-
A practical terminology guide explaining whether MS/MS and MS2 are the same, how they relate to MS1, and how to choose clear language for proteomics and protein identification projects.
-
• Advancing Antibody Research: The Power of Polyclonal Antibody Sequencing
Discover how polyclonal antibody sequencing advances antibody research through reagent documentation, batch comparability, reproducibility, and sequence-informed experimental design.
-
• What is the difference between native and denatured mass spectrometry?
A practical comparison of native and denatured mass spectrometry covering key differences, decision dimensions, method selection by project goal, and complementary use in protein characterization.
-
• What is Native Mass Spectrometry?
A clear technical guide to native mass spectrometry covering definition, working principles, advantages, limitations, and common applications in protein and biotherapeutic analysis.
-
• Native Mass Spectrometry (MS) Overview
An overview of native mass spectrometry explaining what native MS measures, how it differs from other MS workflows, typical outputs, and key application areas in protein characterization.
-
• PhIP-Seq Study Design for Disease and Control Cohorts
A practical guide to PhIP-Seq study design for disease and control cohorts, covering inclusion criteria, control matching, sample size, matrix and library choice, batch planning, and analysis alignment.
-
• How Many Control Samples Are Needed for PhIP-Seq?
A practical guide to PhIP-Seq control sample planning, covering control types, minimum numbers by study design, case-control balance, and matrix-matched control requirements.
-
• Why PhIP-Seq Candidates Require Orthogonal Validation
A technical guide explaining why PhIP-Seq candidates require orthogonal validation, covering false-confidence sources, validation pathways, and phased confirmation before autoantigen claims.
How to order?
